ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY >

2019 , Vol. 3 >Issue 4: 197 - 199

DOI: https://doi.org/10.37015/AUDT.2019.191208

Case Report

Differences in CEUS and CE-MRI Appearance of HCC: A Case Report

  • Ma, MD Li ,
  • Liang, MD Wenzhao ,
  • Zhu, MD Yupeng ,
  • Zhu, MD Yingqiao ,
  • Zhang, MD Dezhi
Expand
  • a Department of Abdomen Ultrasound, First Hospital of Jilin University, Changchun, Jilin, China
    b Department of Neurology, China- Japan Union Hospital of Jilin University, Changchun, Jilin, China

Received date: 2018-12-27

  Online published: 2019-12-25

Fold

Abstract

Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for more than 90% of liver cancers. It results in between 250,000 and 1 million deaths globally per annum. Unlike other cancers, HCC can usually be diagnosed on imaging studies only, without tissue sampling confirmation. Nowadays, contrast-enhanced ultrasound (CEUS) is usually used to detect HCC in the clinic because it’s more applicable for the characterization of a known lesion. But the sensitivity of CEUS is less than 50% for small tumors.

Key words： Hepatocellular carcinoma; Contrast-enhanced ultrasound; Contrasted-enhanced magnetic resonance imaging

Cite this article

Ma, MD Li , Liang, MD Wenzhao , Zhu, MD Yupeng , Zhu, MD Yingqiao , Zhang, MD Dezhi . Differences in CEUS and CE-MRI Appearance of HCC: A Case Report[J]. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY, 2019 , 3(4) : 197 -199 . DOI: 10.37015/AUDT.2019.191208

References

[1] European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56:908-43.
[2] Willatt J, Ruma JA, Azar SF, Dasika NL, Syed F. Imaging of hepatocellular carcinoma and image guided therapies - how we do it. Cancer Imaging 2017; 17:9.
[3] Jang HJ, Yu H, Kim TK. Contrast-enhanced ultrasound in the detection and characterization of liver tumors. Cancer Imaging 2009; 9:96-103.
[4] Yamashita T, Kitao A, Matsui O, Hayashi T, Nio K, Kondo M, et al. Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology 2014; 60:1674-85.
Options
Outlines

/

〈 〉

Content
For Authors
For Reviewers
Article Category
Publisher Policies
About
Top 10 Rankings

Share: WeChat

Copyright ©2018 Advanced Ultrasound in Diagnosis and Therapy

|

Creative Commons License Advanced Ultrasound in Diagnosis and Therapy (AUDT)  is licensed under a Creative Commons Attribution 4.0 International License.